findmyKOL
Clinical trialNCT00506493CompletedPhase 3Interventional

Medtronic Concomitant Utilization of Radio Frequency for Atrial Fibrillation CURE-AF/Persistent

SponsorMedtronic Cardiac SurgeryEnrollment75Atrial Fibrillation
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This investigation is a prospective, nonrandomized multicenter clinical trial evaluating the outcome of patients with atrial fibrillation (AF) requiring concomitant open heart surgery plus the Cardioblate Surgical Ablation System using the modified Maze III procedure. The trial population includes patients requiring valve replacements or repairs, atrial septal defect (ASD) repairs, patent foramen ovale (PFO) closure or coronary artery bypass graft (CABG) procedures. The study objectives are to demonstrate that the Medtronic Cardioblate Surgical Ablation System can safely and effectively treat persistent AF patients.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Southwest Heart and Lung

    Phoenix, Arizona, United States

  • East Bay Cardiovascular & Thoracic Associates

    Concord, California, United States

  • University of Southern California

    Los Angeles, California, United States

  • Eisenhower Medical Center

    Palm Springs, California, United States

  • Cardiac Surgical Associates of Florida

    St. Petersburg, Florida, United States

  • Northwestern Memorial Hospital

    Chicago, Illinois, United States

  • Mayo/st. Mary'S Hospital

    Rochester, Minnesota, United States

  • Washington University School of Medicine

    St Louis, Missouri, United States

  • Englewood Hospital and Medical Center

    Englewood, New Jersey, United States

  • New Mexico Heart Institute

    Albuquerque, New Mexico, United States

  • Lenox Hill Hospital

    New York, New York, United States

  • Cleveland Clinic Foundation

    Cleveland, Ohio, United States

  • Hospital of University of Pennsylvania

    Philadelphia, Pennsylvania, United States

  • Inova Fairfax

    Falls Church, Virginia, United States

  • Aurora St. Luke'S Medical Center

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2007
Primary completion
31 Jul 2011
Completion
31 Oct 2011
Last update posted
29 Nov 2023
Registered enrollment
75
Registry id
NCT00506493
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.